Kumamoto, Japan

Susumu Yamaori

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Km Biologics Co., Ltd.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Susumu Yamaori. Retrieved from https://idiyas.com/inventor/susumu-yamaori

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Susumu Yamaori

Introduction

Susumu Yamaori is a notable inventor based in Kumamoto, Japan. He has made significant contributions to the field of vaccine development, particularly in the fight against dengue fever. His innovative work has led to advancements in vaccine safety and efficacy.

Latest Patents

Yamaori holds a patent for a multivalent dengue vaccine composition. This composition comprises a mixture of attenuated dengue viruses from different serotypes. The vaccine is designed to be highly safe and induces a neutralizing antibody response against all four serotypes of the dengue virus. Importantly, it achieves this without developing more than a fixed level of viremia with a single administration. This tetravalent dengue virus formulation is noted for its excellent efficacy and safety.

Career Highlights

Throughout his career, Yamaori has been associated with Km Biologics Co., Ltd., where he has focused on vaccine research and development. His work has been instrumental in creating safer and more effective vaccines for infectious diseases.

Collaborations

Yamaori has collaborated with notable colleagues, including Kengo Sonoda and Yasuhiko Shinmura. These partnerships have contributed to the advancement of his research and the successful development of his patented vaccine.

Conclusion

Susumu Yamaori's contributions to vaccine innovation, particularly in the development of a safe and effective dengue vaccine, highlight his importance in the field of medical research. His work continues to impact public health positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…